Could a cannabis compound help ADHD? new trial tests CBG
NCT ID NCT06115603
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This Phase 2 trial tests whether a single dose of cannabigerol (CBG), a non-psychoactive cannabis compound, can improve attention and reduce hyperactivity in adults with ADHD. 76 participants will receive either 80mg of CBG or a placebo, then complete computer and paper tasks measuring focus, memory, and decision-making. The study aims to see if CBG offers a new way to ease ADHD symptoms.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
cannabigerol (CBG)
What this could lead to
If it works, this could point toward a new, non-stimulant option for easing ADHD symptoms like inattention and impulsivity.
What could go wrong
This is a small, early-phase trial testing only a single dose. It may show no benefit over placebo, and long-term safety and effectiveness are unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATTENTION-DEFICIT / HYPERACTIVITY DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Arkansas
RECRUITINGFayetteville, Arkansas, 72703, United States
Contact Email: •••••@•••••